Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
| ALDX Stock | USD 6.49 0.02 0.31% |
Slightly above 52% of Aldeyra's investor base is interested to short. The analysis of the overall investor sentiment regarding Aldeyra suggests that many traders are impartial. Aldeyra's investing sentiment can be driven by a variety of factors including economic data, Aldeyra's earnings reports, geopolitical events, and overall market trends.
Aldeyra |
LEXINGTON, Mass., September 05, 2024--Aldeyra Therapeutics, Inc. , a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference.
Read at finance.yahoo.com
 |
Aldeyra Fundamental Analysis
We analyze Aldeyra's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aldeyra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aldeyra based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Aldeyra is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Aldeyra Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aldeyra stock to make a market-neutral strategy. Peer analysis of Aldeyra could also be used in its relative valuation, which is a method of valuing Aldeyra by comparing valuation metrics with similar companies.
Peers
Aldeyra Related Equities
| IBRX | Immunitybio | 9.04 | ||||
| BLRX | BioLineRx | 5.70 | ||||
| LXRX | Lexicon Pharmaceuticals | 5.41 | ||||
| LYRA | Lyra Therapeutics | 5.00 | ||||
| PHAT | Phathom Pharmaceuticals | 2.67 | ||||
| ARDX | Ardelyx | 2.30 | ||||
| XFOR | X4 Pharmaceuticals | 2.00 | ||||
| INZY | Inozyme Pharma | 1.48 | ||||
| DAWN | Day One | 0.41 | ||||
| GPCR | Structure Therapeutics | 0.08 | ||||
| TERN | Terns Pharmaceuticals | 0.49 | ||||
| HOOK | Hookipa Pharma | 0.53 | ||||
| CGEM | Cullinan Oncology | 0.63 | ||||
| MCRB | Seres Therapeutics | 1.19 | ||||
| BPMC | Blueprint Medicines | 1.31 | ||||
| ETNB | 89bio | 1.40 | ||||
| ETON | Eton Pharmaceuticals | 2.32 | ||||
| TVTX | Travere Therapeutics | 3.41 | ||||
| VRDN | Viridian Therapeutics | 3.64 | ||||
| TARS | Tarsus Pharmaceuticals | 3.85 |
Additional Tools for Aldeyra Stock Analysis
When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.